Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has updated its date references, removing older dates from June 2023 and adding new dates in April 2025.
    Difference
    0.6%
    Check dated 2025-04-23T15:43:11.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the removal of detailed descriptions of a clinical trial for Head and Neck Squamous Cell Carcinoma (HNSCC) and the addition of a new version revision. Notably, the principal investigator's name and the collaborators have been retained.
    Difference
    53%
    Check dated 2025-04-16T13:10:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:48:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:44:11.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T20:22:19.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T09:35:26.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.